Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Relationship between hearing loss and depression: A cross-sectional analysis from the National Health and Nutrition Examination Survey 2015–2018
Yunfei Tan, Lili Fang, Yichen Zhu, et al.
Journal of Psychiatric Research (2024) Vol. 178, pp. 1-7
Closed Access | Times Cited: 3
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders
Jeetendra Kumar Gupta, Kuldeep Singh, Alok Bhatt, et al.
3 Biotech (2024) Vol. 14, Iss. 11
Closed Access | Times Cited: 2
Risk Factors, Outcomes, and Predictions of Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Infections in Patients with Nervous System Diseases
Li Huang, Jingyang Tang, Gang Tian, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7327-7337
Open Access | Times Cited: 6
Sex differences in the effects of repeated ketamine infusions on bone markers in patients with unipolar and bipolar depression
Xiaofeng Lan, Haiyan Liu, Chengyu Wang, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Is there evidence for using ketamine among individuals with dementia?
A Kapoor, Tanya Peguero Estevez, Carol Chan, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 6
Open Access | Times Cited: 1
Ketamine – An Imperfect Wonder Drug?
Tanner Magruder, Marielle Isenhart, Maximillian V Striepe, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116516-116516
Closed Access | Times Cited: 1
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
Piotr Kawczak, Igor Feszak, Tomasz Bączek
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2283-2283
Open Access | Times Cited: 1
Ketamine: an Emerging Agent in the Management of Neuropsychiatric Disorders
Nathan B. Menke, Elizabeth R. Hoffman, Kelsey Gaylor, et al.
Asian Journal of Psychiatry (2024) Vol. 106, pp. 104351-104351
Closed Access | Times Cited: 1
Integrated network pharmacology and comprehensive bioinformatics identifying the mechanisms and molecular targets of Jieyu Anshen Granules for treating comorbidity with Alzheimer's disease and depression
Xin Ren, Ya Wen, Chang Li, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 2, pp. 105485-105485
Open Access | Times Cited: 2
Evaluation of the Effects of Repetitive Anaesthesia Administration on the Brain Tissues and Cognitive Functions of Rats with Experimental Alzheimer’s Disease
Nuray Camgöz Eryılmaz, Mustafa Arslan, Ays̀egül Küçük, et al.
Medicina (2024) Vol. 60, Iss. 8, pp. 1266-1266
Open Access
Brain-Derived Neurotrophic Factor in Bipolar Disorder
Kenji Hashimoto
Springer eBooks (2024), pp. 1-15
Closed Access
Arketamine: a scoping review of its use in humans
Gustavo C. Leal, Isabel Lima-Araújo, David G. Roiter, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access
Insights Into Retinal Pathologies in Neurological Disorders: A Focus on Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease
Enes Akyüz, Feyza Şule Aslan, Abdulhekim Hekimoglu, et al.
Journal of Neuroscience Research (2024) Vol. 103, Iss. 1
Closed Access
Depression: The Vagus Nerve and Gut-Brain Axis
Kenji Hashimoto
(2024), pp. 1-18
Closed Access
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
Treatment of Chronic Fatigue Syndrome (CFS) in Post-SARS-CoV-2 Infection through combined outpatient Neuromodulation Therapy with Repetitive Transcranial Magnetic Stimulation (rTMS) and Ketamine IV Therapy - A Case Series
Chiara Rolle, Mario H W Scheib, Anja Frank, et al.
(2022)
Open Access
Previous Page - Page 2

Scroll to top